MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 72 filers reported holding MEI PHARMA INC in Q3 2019. The put-call ratio across all filers is 13.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $38,000 | -75.3% | 63,485 | +10.2% | 0.00% | -100.0% |
Q4 2021 | $154,000 | -6.1% | 57,612 | -2.9% | 0.00% | 0.0% |
Q3 2021 | $164,000 | -5.2% | 59,336 | -2.3% | 0.00% | 0.0% |
Q2 2021 | $173,000 | -21.0% | 60,746 | -5.0% | 0.00% | 0.0% |
Q1 2021 | $219,000 | +30.4% | 63,921 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $168,000 | -13.0% | 63,752 | +3.2% | 0.00% | 0.0% |
Q3 2020 | $193,000 | -26.1% | 61,779 | -2.2% | 0.00% | 0.0% |
Q2 2020 | $261,000 | +169.1% | 63,183 | +5.3% | 0.00% | 0.0% |
Q1 2020 | $97,000 | -11.0% | 59,983 | +36.0% | 0.00% | – |
Q4 2019 | $109,000 | +51.4% | 44,089 | +2.5% | 0.00% | – |
Q3 2019 | $72,000 | -33.9% | 43,032 | -0.7% | 0.00% | – |
Q2 2019 | $109,000 | -99.9% | 43,332 | +428.2% | 0.00% | – |
Q1 2014 | $91,299,000 | +42.4% | 8,203 | +2.5% | 0.00% | – |
Q4 2013 | $64,128,000 | -12.2% | 8,006 | +24.3% | 0.00% | – |
Q3 2013 | $73,030,000 | – | 6,440 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 3,018,059 | $4,467,000 | 4.40% |
CAXTON CORP | 885,560 | $1,426,000 | 1.56% |
Vivo Capital, LLC | 9,784,422 | $15,753,000 | 1.43% |
Sio Capital Management, LLC | 2,485,098 | $4,001,000 | 1.34% |
BVF INC/IL | 5,046,272 | $8,124,000 | 0.76% |
NEA Management Company, LLC | 8,533,072 | $13,738,000 | 0.72% |
Boxer Capital, LLC | 2,913,091 | $4,690,000 | 0.32% |
Perceptive Advisors | 3,030,440 | $4,879,000 | 0.13% |
WASATCH ADVISORS LP | 5,070,718 | $8,164,000 | 0.08% |
KNOTT DAVID M | 38,590 | $62,000 | 0.04% |